#biib122
Latest news and interesting information about biib122.
Denali stock drops after Parkinson drug fails trial
Denali Therapeutics stock falls after Parkinson's drug BIIB122 fails Phase 2b trial. Shares drop 2.9% premarket.
...
Latest news and interesting information about biib122.